Oncology

Microbial metabolite may boost antitumor immunity in aggressive breast cancer

Researchers have found that a specific microbial metabolite may boost the efficacy of anticancer therapy in people with TNBC. The findings could inform the development of improved treatments for TNBC.

Lung microbiota may influence outcome of bone marrow transplant

New research investigates the role of lung microbiota in pediatric patients with lung infection or injury after bone marrow transplantation.

Specific gut bacteria may improve immunotherapy for melanoma

The findings could help to develop microbiota-based strategies to advance immunothery treatments for melanoma.

A probiotic boosts the efficacy of anti-cancer therapy, small trial suggests

Researchers have found that combining a probiotic product with immunotherapy may boost anti-tumor responses in people with advanced kidney cancer.

Akkermansia muciniphila can be a biomarker of response to cancer therapy, study suggests

Akkermansia can be used as a biomarker to identify who is likely to respond to treatment with immune checkpoint inhibitors. A new study published in Nature Medicine claims

A high-fiber diet may improve melanoma patients’ response to immunotherapy

A high-fiber diet may improve melanoma patients’ response to immunotherapy. A new study published in Science claims.

How a gut microbe may suppress colorectal cancer growth

Lactobacillus reuteri can protect against colorectal cancer through reuterin, one of its metabolites. A new study published in Cencer Cell claims

Biomaterials may boost efficacy of oral cancer therapy by modulating the microbiota

Specific bacteria in combination with a hydrogel containing silver nanoparticles can reduce tumor growth in mice with a cancer of the oral cavity. A new study published in Nature Biomedical…

Mouth microbiota may influence the efficacy of cancer radiotherapy

The mouth microbiota may be used as a potential biomarker and target for the diagnosis and treatment of colorectal cancer. A new study pulished in Cell Reports claims.

How some gut microbes can drive resistance to prostate cancer treatment

Some individuals with advanced prostate cancer develop resistance to ADT, which promotes the expansion of specific gut bacteria that can synthesize androgens.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top